Tag: Nasdaq

Yield10 Bioscience delisted from Nasdaq as of May 16

Yield10 Bioscience delisted from Nasdaq as of May 16

May 20, 2024 |

In Massachusetts, Yield10 Bioscience announced the company received a final delisting notice from Nasdaq. The delisting is a result of failure to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1) requiring companies listed on the Nasdaq Capital Market to maintain […]

Read More

Nasdaq warns Evogene of delisting risk due to low share price

Nasdaq warns Evogene of delisting risk due to low share price

March 20, 2024 |

In Israel, Evogene Ltd. received a letter from the Nasdaq Stock Market LLC indicating that the company is currently not in compliance with Nasdaq Rule 5550(a)(2), as the company’s closing bid price for its ordinary shares has been below $1.00 per share for the last 30 consecutive business days. The Nasdaq Stock Market Rules provide […]

Read More